(Q113890862)

English

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

clinical trial

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers: A Randomized, Comparator-controlled, Double-blind, Parallel-group, Multi-center Study (English)

0 references

medical condition

diabetic foot

0 references

start time

14 July 2020

0 references

end time

31 December 2021

0 references

number of participants

104

0 references

clinical trial phase

phase III clinical trial

0 references

research site

St. Paul's Hospital

0 references

Seoul National University Bundang Hospital

0 references

Asan Medical Center

0 references

research subject recruitment status

unknown

0 references

minimum age

19 year

0 references

maximum age

75 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT04569409

0 references

(Q113890862)

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)